Emerging noninvasive biochemical measures to predict cardiovascular risk

Marco Pahor, Marshall Elam, Robert J. Garrison, Stephen B. Kritchevsky, William B. Applegate

Research output: Contribution to journalReview article

62 Citations (Scopus)

Abstract

New predictors of cardiovascular events are needed to improve the accuracy of risk stratification. Such predictors should be easily measurable in the population and potentially modifiable. This review reports on new biomarkers that are closely linked to the pathogenic mechanisms underlying the progression of the atherosclerotic plaque leading to rupture and thrombosis that ultimately precipitate acute clinical events, such as stroke and myocardial infarction. These risk factors have been associated with subclinical or clinical cardiovascular disease in large populations and include markers of lipoprotein and lipid metabolism, vitamin B12 metabolism, fibrinolysis, coagulation, inflammation, infection, endothelial dysfunction, the angiotensin system, and oxidative stress. For other key processes of atherosclerosis and cardiac disease, such as apoptosis or programmed cell death, there are currently no markers that can be measured noninvasively. Atherosclerosis is a multifactorial condition and possibly only a subset of factors are the main determinants of disease in a given patient. A better definition of the cardiovascular risk profile will help to better target primary and secondary prevention. Further epidemiological studies are needed to characterize the actual predictive and clinical value of these new emerging cardiovascular biomarkers.

Original languageEnglish (US)
Pages (from-to)237-245
Number of pages9
JournalArchives of Internal Medicine
Volume159
Issue number3
DOIs
StatePublished - Feb 8 1999

Fingerprint

Atherosclerosis
Biomarkers
Angiotensins
Fibrinolysis
Atherosclerotic Plaques
Primary Prevention
Vitamin B 12
Secondary Prevention
Lipid Metabolism
Population
Lipoproteins
Epidemiologic Studies
Rupture
Heart Diseases
Oxidative Stress
Thrombosis
Cell Death
Cardiovascular Diseases
Stroke
Myocardial Infarction

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Emerging noninvasive biochemical measures to predict cardiovascular risk. / Pahor, Marco; Elam, Marshall; Garrison, Robert J.; Kritchevsky, Stephen B.; Applegate, William B.

In: Archives of Internal Medicine, Vol. 159, No. 3, 08.02.1999, p. 237-245.

Research output: Contribution to journalReview article

Pahor, Marco ; Elam, Marshall ; Garrison, Robert J. ; Kritchevsky, Stephen B. ; Applegate, William B. / Emerging noninvasive biochemical measures to predict cardiovascular risk. In: Archives of Internal Medicine. 1999 ; Vol. 159, No. 3. pp. 237-245.
@article{8576489dee8d43eaab06c4b222d15691,
title = "Emerging noninvasive biochemical measures to predict cardiovascular risk",
abstract = "New predictors of cardiovascular events are needed to improve the accuracy of risk stratification. Such predictors should be easily measurable in the population and potentially modifiable. This review reports on new biomarkers that are closely linked to the pathogenic mechanisms underlying the progression of the atherosclerotic plaque leading to rupture and thrombosis that ultimately precipitate acute clinical events, such as stroke and myocardial infarction. These risk factors have been associated with subclinical or clinical cardiovascular disease in large populations and include markers of lipoprotein and lipid metabolism, vitamin B12 metabolism, fibrinolysis, coagulation, inflammation, infection, endothelial dysfunction, the angiotensin system, and oxidative stress. For other key processes of atherosclerosis and cardiac disease, such as apoptosis or programmed cell death, there are currently no markers that can be measured noninvasively. Atherosclerosis is a multifactorial condition and possibly only a subset of factors are the main determinants of disease in a given patient. A better definition of the cardiovascular risk profile will help to better target primary and secondary prevention. Further epidemiological studies are needed to characterize the actual predictive and clinical value of these new emerging cardiovascular biomarkers.",
author = "Marco Pahor and Marshall Elam and Garrison, {Robert J.} and Kritchevsky, {Stephen B.} and Applegate, {William B.}",
year = "1999",
month = "2",
day = "8",
doi = "10.1001/archinte.159.3.237",
language = "English (US)",
volume = "159",
pages = "237--245",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Emerging noninvasive biochemical measures to predict cardiovascular risk

AU - Pahor, Marco

AU - Elam, Marshall

AU - Garrison, Robert J.

AU - Kritchevsky, Stephen B.

AU - Applegate, William B.

PY - 1999/2/8

Y1 - 1999/2/8

N2 - New predictors of cardiovascular events are needed to improve the accuracy of risk stratification. Such predictors should be easily measurable in the population and potentially modifiable. This review reports on new biomarkers that are closely linked to the pathogenic mechanisms underlying the progression of the atherosclerotic plaque leading to rupture and thrombosis that ultimately precipitate acute clinical events, such as stroke and myocardial infarction. These risk factors have been associated with subclinical or clinical cardiovascular disease in large populations and include markers of lipoprotein and lipid metabolism, vitamin B12 metabolism, fibrinolysis, coagulation, inflammation, infection, endothelial dysfunction, the angiotensin system, and oxidative stress. For other key processes of atherosclerosis and cardiac disease, such as apoptosis or programmed cell death, there are currently no markers that can be measured noninvasively. Atherosclerosis is a multifactorial condition and possibly only a subset of factors are the main determinants of disease in a given patient. A better definition of the cardiovascular risk profile will help to better target primary and secondary prevention. Further epidemiological studies are needed to characterize the actual predictive and clinical value of these new emerging cardiovascular biomarkers.

AB - New predictors of cardiovascular events are needed to improve the accuracy of risk stratification. Such predictors should be easily measurable in the population and potentially modifiable. This review reports on new biomarkers that are closely linked to the pathogenic mechanisms underlying the progression of the atherosclerotic plaque leading to rupture and thrombosis that ultimately precipitate acute clinical events, such as stroke and myocardial infarction. These risk factors have been associated with subclinical or clinical cardiovascular disease in large populations and include markers of lipoprotein and lipid metabolism, vitamin B12 metabolism, fibrinolysis, coagulation, inflammation, infection, endothelial dysfunction, the angiotensin system, and oxidative stress. For other key processes of atherosclerosis and cardiac disease, such as apoptosis or programmed cell death, there are currently no markers that can be measured noninvasively. Atherosclerosis is a multifactorial condition and possibly only a subset of factors are the main determinants of disease in a given patient. A better definition of the cardiovascular risk profile will help to better target primary and secondary prevention. Further epidemiological studies are needed to characterize the actual predictive and clinical value of these new emerging cardiovascular biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=0033535117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033535117&partnerID=8YFLogxK

U2 - 10.1001/archinte.159.3.237

DO - 10.1001/archinte.159.3.237

M3 - Review article

VL - 159

SP - 237

EP - 245

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 3

ER -